Related Experiment Video
Updated: Sep 28, 2026
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled
Waldo Mattos1, Sam Lim, Richard Russell
1Department of Thoracic Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, UK.
Background:
Asthma is associated with remodeling of the extracellular matrix (ECM) and increased airway obstruction, and the mechanisms of this process are unknown. Matrix metalloproteinases (MMPs) are a group of enzymes capable of degrading the ECM. They are released along with their inhibitors, tissue inhibitor of MMP (TIMP).
Study Objective:
s: To determine whether severe, persistent asthma is associated with increased levels of MMP-9 in the airway compared with mild asthma, and to assess the effect of both allergen exposure and steroid treatment on MMP-9 and TIMP-1 levels.
Design:
Prospective analysis of levels and activity of MMP-9 and TIMP-1 in BAL fluid (BALF) and induced sputum obtained from asthmatics of differing disease severity. In patients with mild asthma, MMP-9 and TIMP-1 levels were studied in induced sputum following allergen challenge and in BALF after inhaled steroid therapy.
Patients:
Eighteen patients with mild asthma, 10 patients with severe asthma, and 10 nonsmoking, atopic subjects had their sputum studied. Fourteen of the patients with mild asthma underwent allergen challenge. BAL was collected from 16 patients with mild asthma before and after 4 weeks treatment with inhaled budesonide, 800 micro g bid, or placebo.
Results:
Patients with severe asthma had increased levels and activity of sputum MMP-9 in their sputum compared with patients with mild asthma and normal subjects. Allergen challenge increased the MMP-9/TIMP-1 ratio and MMP-9 activity. Inhaled budesonide had no effect on MMP-9 or TIMP-1 in patients with mild asthma.
Conclusions:
MMP-9 may play a role in chronic airway inflammation and remodeling in asthma, as concentrations are increased in severe, persistent asthma and following allergen challenge. Inhaled steroids may not affect MMP-9 and TIMP in patients with mild asthma, and additional studies in patients with more severe asthma are needed.
Insights
Severe asthma is linked to higher matrix metalloproteinase-9 (MMP-9) levels, suggesting a role in airway remodeling. Allergen exposure increases MMP-9 activity, while inhaled steroids show no effect in mild asthma patients.
Area of Science:
- Pulmonary Medicine
- Immunology
- Biochemistry
Background:
- Asthma involves extracellular matrix (ECM) remodeling and airway obstruction.
- Matrix metalloproteinases (MMPs) degrade ECM; tissue inhibitor of MMP (TIMP) regulates them.
Purpose of the Study:
- Compare MMP-9 levels in severe vs. mild asthma.
- Assess allergen exposure and steroid treatment effects on MMP-9 and TIMP-1.
Main Methods:
- Analyzed MMP-9 and TIMP-1 levels/activity in sputum and BAL fluid from mild, severe asthma, and control groups.
- Studied mild asthma patients after allergen challenge and inhaled steroid therapy.
Main Results:
- Severe asthma patients exhibited elevated sputum MMP-9 levels and activity compared to mild asthma and controls.
- Allergen challenge increased the MMP-9/TIMP-1 ratio and MMP-9 activity.
- Inhaled budesonide did not alter MMP-9 or TIMP-1 levels in mild asthma.
Conclusions:
- MMP-9 may contribute to chronic airway inflammation and remodeling in asthma.
- Elevated MMP-9 in severe asthma and post-allergen challenge supports this role.
- Inhaled steroids may not impact MMP-9/TIMP in mild asthma; further research in severe asthma is needed.
Related Concept Videos
01:23Role of Matrix Metalloproteases in Degradation of ECM
A...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema